SS-31 vs NAD+: Which Mitochondrial Peptide for Perimenopause Fatigue?

Fatigue is one of the most consistently reported perimenopause complaints, and both SS-31 and NAD+ show up in research conversations about mitochondrial support. They intervene at different points in the same broader system, which matters for how you think about choosing between them.

BioPure Peptides Code POWER View → Midwest Peptide Code POWER, 10% off View →

NAD+: Replenishing the Coenzyme Pool

NAD+ is a coenzyme mitochondria need broadly across energy metabolism, and its natural decline with age is well documented in the research literature. Direct injectable NAD+ replenishes this pool without relying on oral precursor conversion.

SS-31: Structural Membrane Support

SS-31 works differently — it binds cardiolipin, a phospholipid in the inner mitochondrial membrane essential to the electron transport chain’s structure. Research interest centers on whether stabilizing that membrane structure improves mitochondrial efficiency under stress, a mechanism distinct from simply having more NAD+ available.

Which to Start With

NAD+ has the broader and more established research base for general fatigue and cellular energy, making it the more common starting point. SS-31’s more targeted mitochondrial-membrane mechanism is of interest for those wanting to explore a different angle after establishing a baseline response to NAD+, or for more specifically cardiac- or muscle-fatigue-focused research interest.

Sourcing

Both are available for research purposes through the following vendors.

BioPure Peptides Code POWER View → Midwest Peptide Code POWER, 10% off View →

Frequently Asked Questions

Is SS-31 the same as NAD+?

No. NAD+ is a coenzyme replenished directly. SS-31 is a peptide that binds cardiolipin in the mitochondrial membrane, a structural rather than coenzyme-based mechanism. Both relate to mitochondrial function but through different pathways.

Which should I try first for perimenopause fatigue?

NAD+ has the broader, more established research base for general fatigue and is the more common starting point. SS-31 is worth exploring after establishing a baseline response, or for more specifically targeted research interest.

Can SS-31 and NAD+ be researched together?

They're sometimes discussed together in longevity-stack contexts given their complementary mechanisms, though isolating one at a time is more informative when first exploring either.